Trial Profile
Evaluation of Late Clinical Events After Drug-eluting Versus Bare-metal Stents in Patients at Risk: BAsel Stent Kosten Effektivitats Trial - PROspective Validation Examination Part II (BASKET-PROVE II).
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 05 Jun 2015
Price :
$35
*
At a glance
- Drugs Umirolimus (Primary) ; Aspirin; Everolimus; Prasugrel
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Adverse reactions; Therapeutic Use
- Acronyms BASKET-PROVE II
- 24 Jan 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 24 Jan 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 02 Apr 2012 Planned end date (May 2014) added as reported by ClinicalTrials.gov.